Revenue | ₹10.80Cr |
Net Profits | ₹0.23Cr |
Net Profit Margins | 2.13% |
Concord Drugs Ltd’s revenue fell -15.49% since last year same period to ₹10.80Cr in the Q3 2024-2025. On a quarterly growth basis, Concord Drugs Ltd has generated -12.69% fall in its revenue since last 3-months.
Concord Drugs Ltd’s net profit jumped 195.83% since last year same period to ₹0.23Cr in the Q3 2024-2025. On a quarterly growth basis, Concord Drugs Ltd has generated 475% jump in its net profits since last 3-months.
Concord Drugs Ltd’s net profit margin jumped 213.4% since last year same period to 2.13% in the Q3 2024-2025. On a quarterly growth basis, Concord Drugs Ltd has generated 558.59% jump in its net profit margins since last 3-months.